Signal transduction through the Ras/Erk pathway is essential for the mycoestrogen Zearalenone-induced cell-cycle progression in MCF-7 cells

Molecular Carcinogenesis

Volumn 30, Issue 2, 2001, Pages 88-98

  Calaluce, Robert ^a,b   Kunkel, Mark W ^a,b   Watts, George S ^a,b   Schmelz, Monika ^a   Hao, Junshan ^b   Barrera, Jean ^b   Gleason Guzman, Mary ^a   Isett, Robert ^b   Fitchmun, Mark ^b   Tim Bowden, G ^c   Cress, Anne E ^a   Futscher, Bernard W ^d   Nagle, Raymond B ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d Desmos Inc   (United States)

Author keywords

Apoptosis; Breast cancer; Mycoestrogen; Nongenomic activity

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANNEXIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; LUCIFERASE; MYCOTOXIN; PROPIDIUM IODIDE; ZEARALENONE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CARCINOGENESIS; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL LYSATE; CEREAL; DAIRY PRODUCT; DNA SYNTHESIS; DOWN REGULATION; ENZYME ASSAY; ESTROGEN BLOOD LEVEL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MEAT; NORTHERN BLOTTING; ONCOGENE C MYC; ONCOGENE RAS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADENOVIRIDAE; ANNEXIN A5; BLOTTING, NORTHERN; BLOTTING, WESTERN; BREAST NEOPLASMS; BROMODEOXYURIDINE; CELL CYCLE; CELL CYCLE PROTEINS; CELL SURVIVAL; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DOWN-REGULATION; ESTROGENS, NON-STEROIDAL; FEMALE; FLOW CYTOMETRY; FORMAZANS; GENES, MYC; HUMANS; LUCIFERASES; MICROTUBULE-ASSOCIATED PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; MITOSIS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS P21(RAS); SIGNAL TRANSDUCTION; TETRAZOLIUM SALTS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; ZEARALENONE;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0035120348     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2744(200102)30:2<88::AID-MC1017>3.0.CO;2-E     Document Type: Article

References (74)

1. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer
2. Molecular mechanisms of estrogen carcinogenesis
3. Estrogens and breast cancer
4. Menopause and breast cancer risk
5. Age at menarche. Probability of ovulation and breast cancer risk
6. Breast cancer and the oestrogen window hypothesis
7. Phosphorylation of mammalian CDC6 by Cyclin A/CDK2 regulates its subcellular localization
8. Blood levels of organochlorine residues and risk of breast cancer
9. Pesticides - How research has succeeded and failed in informing policy: DDT and the link with breast cancer
10. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells
11. Plant poisoning in free-living wild animals: A review
12. Temporary infertility in Merino ewes grazing improved pastures in western Australia
13. The retinoblastoma protein pathway in cell cycle control and cancer
14. Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer
15. High organochiorine body burden in women with estrogen receptor-positive breast cancer
16. Occurrence of beta-hexachlorocyclohexane in breast cancer patients
17. Organochlorine compounds in human breast fat from deceased with and without breast cancer and in a biopsy material from newly diagnosed patients undergoing breast surgery
18. Breast cancer and serum organochlorines: A prospective study among white, black, and Asian women
19. Estrogenic activity of DDT analogs and polychlorinated biphenyls
20. Is there an association between exposure to environmental estrogens and breast cancer?
21. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women
22. Dietary isoflavones: Biological effects and relevance to human health
23. Risk assessment of the mycotoxin zearalenone
24. Simultaneous occurrence of deoxynivalenol, zearalenone, and aflatoxin in 1982 scabby wheat from the midwestern United States
25. Comparative study on the natural occurrence of Fusarium mycotoxins (trichothecenes and zearalenone) in corn and wheat from high- and low-risk areas for human esophageal cancer in China
26. Formation of fusarenone X, nivalenol, zearalenone, alpha-trans-zearalenol, beta-trans-zearalenol, and fusarin C by Fusarium crookwellense
27. Trichothecenes, zearalenone, and other carcinogenic metabolites of Fusarium and related microfungi
28. Cyclin D1 protein expression and function in human breast cancer
29. Transmission of zearalenone and its metabolite into ruminant milk
30. Short liquid chromatographic method for determination of zearalenone and alpha-zearalenol
31. Induction of S-phase entry by E2F transcription factors depends on their nuclear localization
32. Effects of the mycotoxin zearalenone on swine reproduction
33. Effects of zearalenone (F2) on estrous activity and reproduction in gilts
34. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity
35. The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas
36. Amplification and over-expression of cyclin D1 in breast cancer detected by immunohistochemical staining
37. Naturally occurring oestrogens in foods - A review
38. Interferences of zearalenone, zearalanol or estradiol-17 beta with the steroid-metabolizing enzymes of the human prostate gland
39. Zeranol: A review of the metabolism, toxicology, and analytical methods for detection of tissue residues
40. Dietary estrogens act through estrogen receptor - Mediated processes and show no antiestrogenicity in cultured breast cancer cells
41. Phytoestrogen interaction with estrogen receptors in human breast cancer cells
42. Dietary estrogens stimulate human breast cells to enter the cell cycle
43. Role of podophyllotoxin the bedding and dietary zearalenone on incidence of spontaneous tumors in laboratory animals
44. A new cellular model of response to estrogens: A bioluminescent test to characterize (anti) estrogen molecules
45. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells
46. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
47. D-type cyclin-dependent kinase activity in mammalian cells
48. The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding see
49. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F
50. A recombinant adenovirus expressing p27Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells
51. D-type cyclins and their cyclin-dependent kinases: G1 phase integrators of the mitogenic response
52. Novel antioestrogens without partial agonist activity
53. In situ c-myc expression and genomic status of the c-myc locus in infiltrating ductal carcinomas of the breast
54. Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells
55. Myc and the cell cycle
56. Cell cycle regulation of human WEE1
57. Alteration of cell cycle-dependent histone phosphorylations by okadaic acid. Induction of mitosis-specific H3 phosphorylation and chromatin condensation in mammalian interphase cells
58. Increased phosphorylation of histone H1 in mouse fibroblasts transformed with oncogenes or constitutively active mitogen-activated protein kinase kinase
59. Rapid histone H3 phosphorylation in response to growth factors, phorbol esters, okadaic acid, and protein synthesis inhibitors
60. 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells
61. c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry
62. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2
63. Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells
64. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation
65. Abundance and subcellular localisation of cyclin D3 in human tumours
66. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells
67. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor
68. Nontranscriptional action of oestradiol and progestin triggers DNA synthesis
69. Steroid-induced androgen receptor estradiol receptor β-Src complex triggers prostate cancer cell proliferation
70. Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint
71. Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis
72. Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium
73. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: Studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells
74. Inhibitors of mammalian G1 cyclin-dependent kinases